Insiders · Profile

Sandrock Alfred

President and CEO at Voyager Therapeutics · Head of Research & Development at Biogen. Filing since 16 Sep 2013. CIK 0001577061

VYGR Voyager Therapeutics, Inc. President and CEO · 10 trades BIIB Biogen Head of Research & Development · 25 trades

Company

Date

Role

Action

Shares

Amount

Of holding

VYGR Voyager Therapeutics, Inc.

2 Apr 2026

President and CEO

Sold on a plan

11,511

$44.55K

2.4%

VYGR Voyager Therapeutics, Inc.

24 Feb 2026

President and CEO

Sold on a plan

14,197

$53.81K

2.8%

VYGR Voyager Therapeutics, Inc.

18 Feb 2026

President and CEO

Sold on a plan

11,732

$40.01K

2.3%

VYGR Voyager Therapeutics, Inc.

10 Feb 2026

President and CEO

Sold at will

12,192

$46.09K

2.3%

VYGR Voyager Therapeutics, Inc.

2 Apr 2025

President and CEO

Sold at will

10,885

$37.34K

2.5%

VYGR Voyager Therapeutics, Inc.

20 Feb 2025

President and CEO

Sold at will

11,702

$49.62K

3.8%

VYGR Voyager Therapeutics, Inc.

11 Feb 2025

President & CEO

Sold at will

16,644

$74.07K

5.1%

VYGR Voyager Therapeutics, Inc.

2 Apr 2024

President and CEO

Sold at will

12,115

$119.45K

3.6%

VYGR Voyager Therapeutics, Inc.

21 Feb 2024

President and CEO

Sold at will

13,033

$97.23K

3.7%

VYGR Voyager Therapeutics, Inc.

3 Apr 2023

President and CEO

Sold at will

7,437

$58.23K

3.3%

7 Jun 2021

Head of Research & Development

Sold, plan not stated

7,672

$3.38M

43.0%

4 Nov 2020

EVP, Research & Development

Sold, plan not stated

1,500

$525.00K

10.3%

27 Feb 2018

EVP, Chief Medical Officer

Sold, plan not stated

259

$75.32K

3.8%

23 Feb 2018

EVP, Chief Medical Officer

Sold, plan not stated

908

$266.44K

12.2%

20 Feb 2018

EVP, Chief Medical Officer

Sold, plan not stated

743

$216.96K

10.2%

15 Feb 2018

EVP, Chief Medical Officer

Sold, plan not stated

1,294

$386.71K

15.1%

3 Apr 2017

EVP CMO Neuro & Neurodegenerat

Sold, plan not stated

1,981

$542.95K

21.9%

1 Mar 2017

EVP CMO Neuro & Neurodegenerat

Sold, plan not stated

973

$282.24K

9.7%

25 Feb 2016

EVP CMO Neuro & Neurodegenerat

Sold, plan not stated

183

$47.93K

2.2%

17 Feb 2016

EVP CMO Neuro & Neurodegenerat

Sold, plan not stated

722

$184.95K

8.3%

9 Feb 2016

EVP CMO Neuro & Neurodegenerat

Sold, plan not stated

852

$210.05K

9.9%

4 Dec 2015

EVP CMO Neuro & Neurodegenerat

Sold, plan not stated

441

$122.16K

5.4%

27 Mar 2015

Grp SVP, Chief Medical Officer

Sold, plan not stated

430

$184.95K

4.8%

2 Mar 2015

Grp SVP, Chief Medical Officer

Sold, plan not stated

3,174

$1.30M

26.1%

17 Feb 2015

Grp SVP, Chief Medical Officer

Sold, plan not stated

418

$162.65K

2.7%

10 Feb 2015

Grp SVP, Chief Medical Officer

Sold, plan not stated

1,143

$455.04K

7.3%

9 Feb 2015

Grp SVP, Chief Medical Officer

Sold, plan not stated

856

$340.73K

5.5%

4 Dec 2014

Grp SVP, Chief Medical Officer

Sold, plan not stated

440

$152.19K

2.9%

4 Mar 2014

Grp SVP, Chief Medical Officer

Sold, plan not stated

3,171

$1.09M

17.1%

26 Feb 2014

Grp SVP, Chief Medical Officer

Sold, plan not stated

1,048

$358.59K

4.7%

13 Feb 2014

Grp SVP, Chief Medical Officer

Sold, plan not stated

425

$134.48K

1.9%

11 Feb 2014

Grp SVP, Chief Medical Officer

Sold, plan not stated

2,085

$655.34K

13.2%

4 Dec 2013

Grp SVP, Chief Medical Officer

Sold, plan not stated

439

$125.51K

3.1%

22 Oct 2013

Grp SVP, Chief Medical Officer

Sold, plan not stated

15,030

$3.76M

50.9%

16 Sep 2013

Grp SVP, Chief Medical Officer

Sold, plan not stated

9,820

$2.36M

40.4%

35 decisions on file.